Biodelivery sciences international, inc. (BDSI)
CashFlow / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11
Operating activities:
Net loss

4,966

-696

354

-11,130

-3,833

-7,008

-6,380

-9,770

-10,709

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net (loss) income

-

-

-

-

-

-

-

-

-

-

-11,951

-14,879

48,325

-15,942

-15,977

-16,486

-18,733

10,172

-20,440

-19,211

-8,193

-17,646

-25,256

-6,672

-4,644

-12,769

-18,486

-13,415

-12,722

8,596

-17,477

3,782

6,750

-4,083

-5,123

-5,098

-9,019

Adjustments to reconcile net loss to net cash flows from operating activities
Depreciation and amortization

21

-

85

83

85

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

14

11

-

250

319

366

-654

375

372

372

-545

335

326

326

Depreciation

-

-

-

-

-

-

-

-

230

-

-

-

111

112

113

126

86

81

81

82

85

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accretion of debt discount and loan costs

65

67

67

10,740

634

1,185

1,171

1,157

625

451

450

451

1,040

100

99

99

99

100

122

116

162

160

161

160

161

-

-

-

-

-

-

-

-

-

-

-

-

Amortization of intangible assets

1,781

1,916

1,897

1,898

1,289

1,332

1,290

1,289

1,289

1,297

1,368

1,366

1,369

243

243

242

243

242

243

243

242

244

243

242

243

-

-

-

-

-

-

-

-

-

-

-

-

Provision for inventory obsolescence

405

140

-92

0

149

-452

-16

478

-66

-

-

-132

153

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Derivative loss (gain)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-5,685

-4,121

-4,825

-378

-917

392

1,024

3,277

-3,525

-3,478

-1,867

431

2,472

1,046

-487

Stock-based compensation expense

1,520

1,438

1,267

1,570

1,141

1,045

892

1,083

2,921

4,578

4,223

2,930

3,070

3,331

4,143

3,346

4,111

1,546

5,045

4,151

3,507

2,026

2,378

1,332

1,147

839

1,122

781

584

530

388

238

461

220

557

202

246

Deferred income taxes

-

-

-

-

-

-

-

-

-

0

0

0

-15,972

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Bargain purchase gain

-

-

-

-

-

-

-

-

-

0

0

0

27,336

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Purchase of Arcion license with common stock

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-0

0

0

2,072

-

-

-

-

-

-

-

-

Changes in assets and liabilities, net of effect of acquisition:
Accounts receivable

6,324

5,368

8,543

8,871

2,381

1,059

3,158

1,287

-864

-1,338

4,764

-204

2,662

261

681

276

-356

1,064

-120

-1,505

-109

2,936

-12,435

10,108

-262

1,908

376

281

-293

496

1

-174

96

-1,551

1,431

-518

108

Inventories

4,096

686

700

2,714

2,002

-480

-750

1,205

-716

-134

325

-2,159

-480

-650

-408

-395

2,263

671

354

-1,017

722

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Prepaid expenses and other assets

-1,169

-1,105

1,576

328

-218

-967

1,999

-672

-782

1,300

-792

-840

-194

-334

858

-203

-118

638

860

44

-177

1,447

835

-103

73

-63

109

-232

254

-1

98

-445

345

-19

-593

461

144

Accounts payable and accrued liabilities

6,920

17,431

5,766

7,264

1,814

-2,380

691

2,295

-3,413

-2,354

5,819

-763

3,942

-884

-221

-3

-438

4,578

2,687

-2,337

127

1,347

3,580

653

-1,255

-955

-821

2,421

-1,299

3,240

1,576

757

-6

-1,964

1,581

-1,173

1,964

Taxes payable

-40

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

85

-

-

-

-

-

-

-

-

Deferred revenue

-

-

-

-

-

-

-

-

-

-

0

0

-21,716

-206

-43

325

-235

14,639

-11

133

-499

1,123

747

1,601

-66

-1,196

-1,772

-1,908

-1,621

-16,268

-1,875

1,202

13,495

-8

-20

-72

108

Net cash flows used in operating activities

-

-

-

-

-

-

-

-

-

-

-

-

-9,002

-12,623

-12,788

-11,915

-16,656

28,985

-13,367

-14,345

-5,005

-18,034

-2,061

-9,349

611

-

-

-

-

-

-

-

-

-

-

-

-

Net cash flows used in operating activities

6,387

16,921

-1,475

-1,488

-2,886

-5,838

-6,530

-4,984

-6,761

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-13,522

-

-13,301

10,452

22,500

-4,350

-5,980

-6,804

-6,139

Investing activities:
Product acquisitions

-

-

-

-

-

0

0

0

1,951

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Acquisitions of equipment

0

0

0

0

79

-43

33

49

73

-

-

-

-

89

67

13

236

82

36

439

144

49

534

178

842

-

-

-

-

6

7

0

24

72

86

126

1

Purchase of intangible assets

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

1,050

-

-

-

-

Net cash flows used in investing activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-89

-67

-13

-236

-82

-36

-439

-144

-49

-534

-178

-842

-

-

-

-

-

-

-

-

-

-

-

-

Net cash flows used in investing activities

0

-10,011

0

-20,674

-79

43

-33

-49

-2,024

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-7

0

-1,074

-72

-86

-126

-1

Financing activities:
Equity financing costs

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

40

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from sales of securities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

62,037

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from exercise of stock options

338

1,128

123

598

472

142

222

176

130

-

-

-

-

0

72

0

225

275

177

172

131

7

1,740

273

2,560

-

-

-

-

-

-

-

-

0

0

142

207

Proceeds from issuance of common stock, less underwriters discount

-

-

-

-

-

-

-

-

-

-

-

-

-

0

1

-1

2,460

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

13,996

Proceeds from exercise of common stock warrants

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

2,810

937

1,419

2,575

-

-

-

-

-

-

-

-

-

-

-

-

Payment on note payable

-

-

-

-

-

-

-

-

-

0

0

0

30,000

-

-

-

-

0

0

1,334

2,001

2,000

1,333

2,000

2,000

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from notes payable

-

-

-

-

-

-

-

-

-

15,000

0

0

45,000

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Return of short swing profits

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

6

0

0

0

82

-

-

-

-

-

-

-

-

-

-

-

-

Payment of deferred financing fees

-

-

-

-

-

0

0

0

450

150

0

0

2,798

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash flows (used in) provided by financing activities

-

-

-

-

-

-

-

-

-

-

-

-

12,202

49

73

-1

2,725

228

177

18,980

-1,864

2,761

10,025

-308

65,254

-

-

-

-

-

-

-

-

-

-

-

-

Change in amounts due to related parties

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-60

-

-

-

-

Change in amounts due to related parties

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-1

6

-50

Net cash flows provided by financing activities

338

1,115

123

38,048

472

135

321

48,667

-320

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,597

463

-60

53

-1

1,897

14,153

Net change in cash and cash equivalents

6,725

-

-

-

-2,493

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net change in cash and cash equivalents

-

-

-

-

-

-

-

43,634

-9,105

-

-7,762

-7,711

3,200

-12,663

-12,782

-11,929

-14,167

29,131

-13,226

4,196

-7,013

-15,322

7,430

-9,835

65,023

-15,119

865

-12,236

-13,522

31,870

-11,711

10,915

21,364

-4,369

-6,068

-5,033

8,012

Cash paid for interest

1,442

1,470

1,508

1,900

1,931

1,408

1,396

1,369

1,880

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Cash paid for interest

-

-

-

-

-

-

-

-

-

-

-

-

946

825

687

679

679

684

710

222

269

321

241

392

432

-

-

-

-

-

-

-

-

-

-

-

-

Fair value of bargain purchase price of BELBUCA acquisition

-

-

-

-

-

-

-

-

-

0

0

0

27,300

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-